INTEGRATED SAFETY SUMMARY OF TOFACITINIB IN PSORIATIC ARTHRITIS CLINICAL STUDIES

被引：0
|
作者：
Burmester, G. R. [1 ]
FitzGerald, O. [2 ]
Winthrop, K. [3 ]
Azevedo, V. F. [4 ]
Rigby, W. F. C. [5 ]
Kanik, K. S. [6 ]
Wang, C. [6 ]
Biswas, P. [7 ]
Jones, T. [8 ]
Menon, S. [6 ]
Palmetto, N. [7 ]
Rojo, R. [6 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] St Vincents Univ Hosp, Dublin, Ireland
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Fed Parana, Curitiba, Parana, Brazil
[5] Geisel Sch Med Dartmouth, Lebanon, NH USA
[6] Pfizer Inc, Groton, CT 06340 USA
[7] Pfizer Inc, New York, NY USA
[8] Pfizer Inc, Collegeville, PA USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Integrated Safety Summary of Tofacitinib in Psoriatic Arthritis Clinical Studies
    Burmester, Gerd R.
    FitzGerald, Oliver
    Winthrop, Kevin
    Azevedo, Valderilio F.
    Rigby, William F. C.
    Kanik, Keith S.
    Wang, Cunshan
    Biswas, Pinaki
    Jones, Thomas
    Menon, Sujatha
    Palmetto, Niki
    Rojo, Ricardo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] INTEGRATED SAFETY SUMMARY OF TOFACITINIB IN PSORIATIC ARTHRITIS CLINICAL STUDIES
    Burmester, G.
    FitzGerald, O.
    Winthrop, K.
    Williams, G.
    Azevedo, V. F.
    Rigby, W. F. C.
    Kanik, K.
    Wang, C.
    Biswas, P.
    Jones, T.
    Menon, S.
    Palmetto, N.
    Rojo, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 938 - 938
  • [3] COMPARING TOFACITINIB SAFETY PROFILE IN PATIENTS WITH PSORIATIC ARTHRITIS IN CLINICAL STUDIES WITH REAL-WORLD DATA
    Curtis, J. R.
    Yun, H.
    FitzGerald, O.
    Winthrop, K.
    Azevedo, V. F.
    Burmester, G.
    Rigby, W. F. C.
    Kanik, K. S.
    Rojo, R.
    Menon, S.
    Wang, C.
    Biswas, P.
    Hendrikx, T.
    Palmetto, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 676 - 676
  • [4] Comparing Tofacitinib Safety Profile in Patients with Psoriatic Arthritis in Clinical Studies with Real-World Data
    Curtis, Jeffrey R.
    Yun, Huifeng
    FitzGerald, Oliver
    Winthrop, Kevin
    Azevedo, Valderilio F.
    Burmester, Gerd R.
    Rigby, William F. C.
    Kanik, Keith S.
    Rojo, Ricardo
    Menon, Sujatha
    Wang, Cunshan
    Biswas, Pinaki
    Hendrikx, Thijs
    Palmetto, Niki
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] Tofacitinib in psoriatic arthritis
    Wang, Ting-Shun
    Tsai, Tsen-Fang
    [J]. IMMUNOTHERAPY, 2017, 9 (14) : 1153 - 1163
  • [6] Tofacitinib: A Review in Psoriatic Arthritis
    Julia Paik
    Emma D. Deeks
    [J]. Drugs, 2019, 79 : 655 - 663
  • [7] Tofacitinib for Psoriatic Arthritis REPLY
    Mease, Philip
    Gladman, Dafna
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08): : 775 - 776
  • [8] Tofacitinib: A Review in Psoriatic Arthritis
    Paik, Julia
    Deeks, Emma D.
    [J]. DRUGS, 2019, 79 (06) : 655 - 663
  • [9] SAFETY OF GUSELKUMAB IN PATIENTS WITH PSORIATIC DISEASE: AN INTEGRATED ANALYSIS OF 11 PHASE 2 AND 3 CLINICAL STUDIES IN PSORIASIS AND PSORIATIC ARTHRITIS
    Strober, Bruce
    Coates, Laura
    Yu, Jenny
    Rowland, Katelyn
    Leibowitz, Evan
    Miller, Megan
    Kollmeier, Alexa
    Li, Shu
    Wang, Yanli
    Chan, Daphne
    Chakravarty, Soumya
    Yang, Ya-Wen
    Shawi, May
    Lebwohl, Mark
    Rahman, Proton
    [J]. RHEUMATOLOGY, 2023, 62
  • [10] Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of 11 Phase 2/3 Clinical Studies in Psoriasis and Psoriatic Arthritis
    Strober, Bruce
    Coates, Laura
    Yu, Jenny
    Rowland, Katelyn
    Leibowitz, Evan
    Miller, Megan
    Kollmeier, Alexa
    Li, Shu
    Wang, Yanli
    Chan, Daphne
    Chakravarty, Soumya
    Yang, Ya-Wen
    Shawi, May
    Lebwohl, Mark
    Rahman, Proton
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4199 - 4202
12345